Sun Ling, Hua Rui-Xue, Wu Yu, Zou Lu-Xi
Department of Nephrology, Xuzhou Central Hospital, Xuzhou, China.
Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, China.
Kidney Res Clin Pract. 2023 Sep;42(5):639-548. doi: 10.23876/j.krcp.22.161. Epub 2023 Jul 20.
Acute-on-chronic kidney disease (ACKD) increases the risk of progression of chronic kidney disease (CKD). This study aimed to evaluate the ability of a novel criteria of reference change value of the serum creatinine optimized criteria for acute kidney injury in CKD (cROCK) to detect ACKD patients.
This was a retrospective observational study with a 3-year follow-up. All included patients with CKD stage 3 were evaluated using cROCK, Kidney Disease Improving Global Outcomes (KDIGO), and their combined criteria. The renal composite endpoints, major adverse cardiovascular events (MACEs), and all-cause mortality were recorded as clinical outcomes.
A total of 812 patients was enrolled. The cROCK criteria detected more ACKD events than did the KDIGO (68.0% vs. 59.5%, p < 0.001). Compared to KDIGO (-) & cROCK (-) group, ACKD patients diagnosed by cROCK had significantly higher hazard ratio [HR] for renal composite endpoints (HR, 3.591; p < 0.001), MACEs (HR, 1.748; p < 0.001), and all-cause mortality (HR, 2.985; p < 0.001). The patients in KDIGO (+) & cROCK (+) group had the lowest survival probability when considering renal composite endpoints, MACEs, and all-cause mortality (all p < 0.001). Furthermore, cROCK resulted in the largest area under the receiver operating characteristic curve (AUC) for predicting renal composite endpoints, and the combined criteria led to the largest AUC for predicting MACEs and allcause mortality.
Compared to the KDIGO, the cROCK detected more ACKD events. Combining both cROCK and KDIGO criteria might improve the predictive ability for long-term outcomes in ACKD patients.
急性肾损伤合并慢性肾脏病(ACKD)会增加慢性肾脏病(CKD)进展的风险。本研究旨在评估一种新型的血清肌酐参考变化值标准——慢性肾脏病急性肾损伤优化标准(cROCK)检测ACKD患者的能力。
这是一项为期3年随访的回顾性观察研究。所有纳入的3期CKD患者均采用cROCK、改善全球肾脏病预后组织(KDIGO)标准及其联合标准进行评估。记录肾脏复合终点、主要不良心血管事件(MACE)和全因死亡率作为临床结局。
共纳入812例患者。cROCK标准检测到的ACKD事件比KDIGO标准更多(68.0%对59.5%,p<0.001)。与KDIGO(-)&cROCK(-)组相比,经cROCK诊断的ACKD患者发生肾脏复合终点的风险比[HR]显著更高(HR,3.591;p<0.001),MACE(HR,1.748;p<0.001),以及全因死亡率(HR,2.985;p<0.001)。在考虑肾脏复合终点、MACE和全因死亡率时,KDIGO(+)&cROCK(+)组患者的生存概率最低(均p<0.001)。此外,cROCK在预测肾脏复合终点时的受试者工作特征曲线下面积(AUC)最大,联合标准在预测MACE和全因死亡率时的AUC最大。
与KDIGO相比,cROCK检测到更多的ACKD事件。将cROCK和KDIGO标准相结合可能会提高对ACKD患者长期结局的预测能力。